PD-L1 targeted peptide demonstrates potent antitumor and immunomodulatory activity in cancer immunotherapy
Article in Frontiers in Immunology (April 2024)
The most recent citing publications are shown below. View all 69 publications that cite this research output on Dimensions.
Article in Frontiers in Immunology (April 2024)
Article in Nature Reviews Clinical Oncology (February 2024)
Article in Frontiers in Immunology (February 2024)